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Orienting behaviorObjective: Objective markers of chronic pain severity are needed when examining and treating patients with
chronic pain whose suffering may be overstated or underestimated. This study tested a hypothesis that the
strength of cardiovascular (CV) reactivity in response to a social evaluative threat and orthostatic challenge is a
reliable index of severity of pain-related complaints.
Methods:Measurement of CV reactivity and response styles in 34 men and 16 women with chronic pain from
different bodily injuries, were retrieved from a larger database of patients. Measurement of CV reactivity in re-
sponse to a postural challenge was repeated twice (sessions 1 and 2) on the same day of a medical examination
which includes a psychosocial evaluation.
Results: A decrease in systolic blood pressure (SBP) from session 1 to session 2 was found in subjects with low
pain severity scores, but not in those with high pain severity scores. High scores for pain catastrophizing/
magniﬁcation and pain-related emotional distress were independently associated respectively with a SBP
increase at an early-point in time and a SBP decrease at a mid-point in time after standing up from lying
down. Stronger heart rate reactivity responses to orthostatic challenge indicated greater protection against the
presence of these chronic pain symptoms.
Conclusions: This biobehavioral protocol enables measurement of chronic pain suffering and protection in three
dimensions: physical, emotional, and cognitive.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Clinical indices of disease severity, body impairment, and nociception
using traditional physical, morphologic, imaging, or serologic examina-
tion protocols are only weakly related to self-reports of chronic pain se-
verity, frequency and number of pain episodes, and disabling functional
impairments [1–3]. The challenge is especially relevant in children,
older adults, and persons with limited education or ability to communi-
cate [4,5] and in individuals with traumatic brain injuries, residual post-
concussive syndromes and PTSD, dementia, post-stroke syndromes,
neuropathic pain syndromes, somatoformpain disorders, and personalityydov), sperlo@ucla.edu
. This is an open access article underdisorders [6–11] whose self-reported suffering related to chronic pain
may be intentionally or unintentionallymisrepresented as a consequence
of “illness behavior” [12].
Prior studies have emphasized the importance of pain in blood pres-
sure (BP) regulation [13–17]. They show that pain modulates the activity
of neurons responsible for controlling baroreceptor responses and that
pain may increase hypertension risk in people with chronic pain. Neural
components mediating baroreceptor and nociceptive signals are func-
tionally intertwined within the nervous system [18–20]. Evidence
suggests that nociceptive stimulation increases BP by attenuating the car-
diac baroreﬂex and by increasing sympathetic nervous system activity
[21–23]. Resting systolic BP (SBP) and baroreceptor sensitivity were pos-
itively related to pain threshold and tolerance in healthy people [24,25].
However, these relationships are not present in young patients with
chronic pain [26]. In older patients with chronic pain, the relationshipsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tive, and higher resting SBP is already associatedwith lower baroreceptor
sensitivity [25]. Taken together, these ﬁndings suggest that pain chronic-
itymaymoderate the relationship between baroreﬂexmechanisms regu-
lating BP and pain sensation intensity.
Postural (orthostatic) change from lying to standing is a gravity in-
duced biological challenge that triggers several successive evolutionary-
developed physiological processes for maintaining BP level. It corre-
sponds to alertness behavior most activatedwhen standing up to protect
against light-headedness and fainting [27–29]. Baroreceptors play a pri-
mary role in controlling these processes by causing both parasympathetic
withdrawal and sympathetic activation [30–32]. Systolic blood pressure
ﬂuctuations in earlier response to orthostatic challenge (around the 1st
minute after standing up) were found to correlate with pharmacological
and non-pharmacological indicators of baroreﬂex functioning [33].
Deeper and delayed orthostatic fall was associatedwith lower barorecep-
tor sensitivity or transfer gain function. Other baroreﬂexmechanisms like
cardiac and vascular baroreﬂex resetting (vagal withdrawal and sympa-
thetic activation) can also be involved in bloodpressure regulation during
orthostasis [32] and all these mechanisms may be impaired in patients
with chronic pain [34].
A study of orthostatic cardiovascular (CV) responses in chronic pain
patients found that the ability to enhance sympathetic activation of
blood vessels and the withdrawal of vagal modulation of the sinoatrial
node for maintaining BP level is signiﬁcantly reduced [35]. Poor ortho-
static CV reactivity (CVR) is considered to result from inadequate
triggering of baroreﬂex mechanisms that regulate common arousal-
and pain-related (analgesic/sedative) systems in those experiencing
greater chronic pain [36–38]. A weak orthostatic CVR and its inversion
due to (de)conditioning (i.e., higher CV activity when lying down com-
pared with standing posture) is found to be a reliable marker or predic-
tor of difference and change in both somatic and mental health [27,39,
40]. This CVR regulated by baroreﬂex activity may also be associated
with the emotional component of chronic pain as a general physiologi-
cal response to the negative affect associated with stressful events [27,
41,42]. A weak or ﬂattened CVR in response to psychological challenges
like mental concentrations and social evaluative threat in patients with
chronic painmay also use the same baroreﬂexmechanisms coupling its
impairment with severity and/or duration of chronic pain [43,44].
Pain is a complex experience associated with sensory events, emo-
tions, thoughts, and physical and interpersonal actions; and with no
valid and reliable method of ‘objective’ quantiﬁcation at present [45].
Therefore, we relied mainly on self-report measures as the ‘gold stan-
dard’ to determine the relationships between chronic pain and physio-
logical measures. Sensory or nociceptive experience (pain severity
including pain intensity and frequency), experience of negative affect
(pain distress or unpleasantness associatedwith anxiety, depression, ir-
ritation, and overall negative mood), experience of negative cognition
or thought disorganization (e.g., pain catastrophizing including help-
lessness, rumination, and magniﬁcation), and experience of physical
(functional) and psychosocial (interpersonal) behavioral problems
have been considered as core experiential dimensions caused by chron-
ic pain [45,46]. Thus the pain experience should be assessed in a com-
plex way and subjective scales should be selected speciﬁcally relevant
for the subjects and objectives of study. Most recommendations for
chronic pain assessment tools have been provided for clinical trials
and vary depending on speciﬁc patient populations and objectives [47,
48]. Instruments that are legally encouraged for use, have a normative
database in the speciﬁc population of injured workers with chronic
pain, and cover all the above mentioned core experiential dimensions
of chronic pain were included in this study [49–52]. Some of these in-
struments measure several dimensions of pain with differing combina-
tions of intensity, affect, interferencewith functioning and thoughts and
certain overlapping was expected, assessed, and controlled for.
This study evaluates group data from injured workers with
chronic pain. It aims to test the hypothesis that an altered (reduced,inverted, or unstable) CVR in response to physical (orthostatic) and
mental (psychosocial evaluation) stress conditions are related to greater
severity of chronic pain-related complaints, i.e., its sensational, emotional,
cognitive, and behavioral components. The second objective of this study
is to evaluate the independence or uniqueness of these chronic pain's
components in their impact on these CV responses. Scales that measure
behavior, emotional response styles, and maladaptive behavioral re-
sponses in this clinical population are evaluated as possible mediators
and moderators of these relationships.
2. Materials and methods
2.1. Data source
This study relies on clinical and laboratory data obtained from
mandated medical-legal examinations (MLEs) of injured workers with
litigated disability claims. The selected population has several salient
characteristics [53], which provide researchers with several advantages
in achieving previously mentioned objectives: (i) the litigating process
gives unsolicited access to people with remarkably diverse etiological
and pathological sources of chronic pain and its severity. This helps gen-
eralize the expected ﬁndings of a common biomarker of severity, i.e. the
CVR indicator ofmaladaptive neuroplastic change in pain control, to dif-
ferent patients with chronic noncancer pain [18,54]; (ii) the examining
doctor is a neutral panel qualiﬁed medical examiner (PQME) typically
given carte blanche authority to perform whatever diagnostic tests are
required short of authorizing hospitalization; and (iii) injured workers
are legally required to attend this examination but nonetheless asked
to initially give written informed consent regarding no privacy, conﬁ-
dentiality, or future treatment relationship. The MLEs were performed
by a PQME according to the California Labor Code mandates for medi-
cal–legal examinations. At no point in time was the injured worker
ever identiﬁed as a research subject participating in a research study.
MLEs of injured workers with a litigated injury claim are not voluntary.
The situation under which all subjects were being examined could
bias self-reports of pain severity. Validity MMPI-2 scales were used
(see below) to control for this bias as recommended in this population
[55]. We used these validity scores in mediation andmoderation analy-
ses for assessing if an over- or under-reporting strategy of subjects pro-
duces/mediates or biases/modiﬁes the expected relationships between
CVR and pain scores. It allowed us to additionally evaluate the reliability
of CVR metrics when assessing chronic pain severity.
Survey data of MLEs over the past 3 years are retrospectively
analyzed to study relationships between subjective measures of pain
and functional disability with orthostatic CV measures. The CV measures
were included in the PQME's assessment protocol to provide a physiolog-
icalmeasure of individual resilience to adversity, i.e., occupational injuries
[27,28,56]. The CV measurement procedure was not considered at the
time for studying or evaluating chronic pain. The approval for publishing
this study was received from the institutional review board (IRB) of the
University of California, Los Angeles (UCLA).
2.2. Procedures.
All the data examined in this study are from injured workers with lit-
igated disputed injury claimsmandated to be examined by SP as a PQME.
100% presented with chronic pain. MLEs are typically conducted over the
course of two days, usually several weeks apart. This enabled a test-retest
clinical assessment protocol. Day one (D-1) assessments were conducted
by a trained technician who supervised administration of self-report
standardized depression, anxiety, and pain questionnaires including
self-reports of functional impairments. The trained technician also admin-
istered the CV measurement protocol and supervised completion of
computer-administered psychodiagnostic and neurocognitive tests by
subjects. Day two (D-2) assessments were conducted by the PQME.
They included an extensive face-to-face medical-legal neuropsychiatric
Table 1
General demographic, health, cardiovascular, injury, pain, and disability characteristics of
the study's sample.
Variables Estimates
(mean [SD])
Age (years at examination) 47.4 (10.9)
Sex Female (N) 16
Male (N) 34
Race White (N) 44
Non-White (N) 6
Ethnicity Hispanic (N) 21
Non-Hispanic
White (N)
23
African (N) 6
Education (years) 11.8 (3.5)
Body mass index (kg/cm2) 31.3 (5.8)
Systolic blood pressure (mm Hg) 126.5 (15.1)
Diastolic blood pressure (mm Hg) 79.7 (8.7)
Mean arterial pressure (mm Hg) 95.3 (10.3)
Pulse pressure (mm Hg) 46.8 (9.7)
Heart rate (bpm) 73.9 (12.0)
Rate pressure product (bpm ∗mm Hg) 9357.0 (1964.1)
Variables Estimates
(mean [SD])
Period from injury to examination (months) 40.1 (25.5)
Whole Person Impairment scorea 42.1 (8.2)
Cumulative trauma or distress Yes (N)
[months]
25 (72.0)
No (N) 25
Pain severity by RDIP 13.8 (4.6)
Pain-related emotional distress by RDIP 6.0 (2.7)
Pain-related activity interference by RDIP 15.6 (7.4)
General pain-related impairment by RDIP 35.3 (12.9)
Pain-related rumination by PCS 60.2 (33.8)
Pain-related helplessness by PCS 63.1 (30.8)
Pain-related magniﬁcation by PCS 66.3 (30.4)
General pain-related catastrophizing by PCS 61.6 (32.9)
Functional disability by PDQ 51.0 (22.2)
Psychosocial disability by PDQ 38.4 (14.4)
General disability by PDQ 89.4 (34.6)
Functional disability by ODI (%) 45.6 (13.2)
RDIP — Ratings Determining Impairment associated with Pain [49]; PCS — Pain
Catastrophizing Scale (scores are presented in percentiles) [58,59]; PDQ— Pain Disability
Questionnaire [51,52]; ODI — Oswestry Disability Index [51,65].
a Whole Person Impairment score was clinically evaluated by the medical examiner
according to the California Labor Code mandates for medical–legal examinations.
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tress and functional impairments with respect to an alleged psychiatric
injury (see details in [53]). Repeat administration of questionnaires and
neurocognitive testing excluding CVmeasurement protocolwas conduct-
ed when determined to be clinically necessary. Typically, both D-1 and
D-2 required approximately 6 hours or more of subject participation on
successive days including allowance for personal time needs.
The history obtained from subjects included completion of a self-
reported comprehensive standardized medical assessment of physical
andmental states with detailed questions about family, developmental,
childhood, educational, functional, employment, and psychosocial his-
tory, past medical, surgical, and injury history, current symptoms, and
current and past medications needed for diagnosis, pain management,
and other conditions. The subjects also completed standardized ques-
tionnaires to assess severity of functional impairments with respect to
activities of daily living (ADL).
Cases were selected for inclusion in analyses if they contained
a complete set of CV readings collected during D-1 together with any
measure of individual physical sensation, emotional, cognitive and
behavioral response styles surrounding their chronic pain. This
includes: pain sensation severity, pain-related emotional distress, pain
catastrophizing cognition (helplessness, rumination, magniﬁcation),
and pain-related disability (see below). Fifty individual (16 women)
records out of 205 inspected cases met the inclusion criteria and all
were accepted for analyses.
2.3. Demographic, medical, and injury characteristics
General demographic, health, cardiovascular, injury, pain, and dis-
ability characteristics of the selected subjects are presented in Table 1.
All selected subjects included in the study received “usual treatment”
in a health-care delivery system that was legislatively driven and
litigious with an emphasis on cost-containment. When subjects were
maximally medically improved, whole person impairment (WPI) was
quantitatively rated from 0%–100%.
Some participants were taking major classes of anti-hypertensive
medications (6%, e.g., angiotensin II receptor antagonist, angiotensin-
converting enzyme inhibitor, selective β1 receptor antagonist) and
psychotropic medications (20%, e.g., barbiturates, tricyclic, atypical or
noradrenergic and speciﬁc serotonergic antidepressants, benzodiaz-
epines, selective serotonin or serotonin-norepinephrine reuptake
inhibitors, antidepressant, atypical antipsychotic). Diagnostically
most participants (84%) were given the DSM IV diagnosis of “Pain
Disorder Associated With Both Psychological Factors and a General
Medical Condition.” Included generalmedical conditions involvemultiple
(from 2 to 9) body regions (e.g., head, jaw, neck, hands, arms, elbows,
forearms, wrists, ﬁngers, upper back and shoulders, mid back, lower
back, chest, abdomen, pubic area, buttock, legs, hamstrings, knees, shins,
calves, feet, soles, and/or toes). Other participants had mild traumatic
brain injury, generalized anxiety-like disorder due to a general medical
condition, or major depressive mood disorder.
2.4. Chronic pain measures
The Ratings Determining Impairment Associated with Pain (RDIP)
consists of 26 numerical rating scales assessing pain severity (chronic
pain experience as a physical sensation including current, worst, aver-
age, aggravated pain intensity and the frequency of pain experience1;
5 scales; range from 0 to 20), and its effects on mood (pain emotional1 Frequency of pain experience as a ‘burdening’ component of chronic pain experience
hasmain impacts on calculating the total score of chronic pain severity than other separate
scales assessing current, worst, average, and aggravated pain intensity integrated in a
‘magnitude’ component of chronic pain experience [49] and on signiﬁcant proﬁle andme-
diation effects of the total score of chronic pain severity obtained in this study (data not
shown).distress including feeling anxious, depressed, irritable, and overall af-
fected; 5 scales; range from0 to 10) and activity (pain activity limitation
including social and physical behavior; 16 scales; range from 0 to 30)
with a total score ranging from 0 to 60 [49]. This instrument from the
AMA Guides for the Evaluation of Permanent Impairment, Fifth Edition
is legally encouraged for use and found to be a reliable alternative to a
clinician-derived behavioral instrument, the Physical Performance Test
[57].
The Pain Catastrophizing Scale (PCS) consists of 13 ﬁve-point scales
(from 0, not at all, to 4, all the time) assessing pain as a negative cogni-
tion (total scores range from 0 to 52) with the tendency (i) to magnify,
heighten, or exaggerate the threat value of pain stimulus or pain sensa-
tions (range 0–12; a ‘magniﬁcation’ subscale), (ii) to perceive oneself as
unable to cope with pain symptoms (i.e., feel helpless in the context of
pain; range 0–24; a ‘helplessness’ subscale), and (iii) to a relative inabil-
ity to inhibit pain-related thoughts in anticipation of, during, or follow-
ing a painful encounter (i.e., rumination with excessive focus on pain
sensations; range 0–16, a ‘rumination’ subscale) [58–60]. Raw scores
were converted to percentiles, whichwere further used in analyses. Per-
centiles of PCS raw scores were suggested to be used in this population
[50]. The percentile scores are derived from a large sample of injured
workers of both sexes with a mean age of 42.2 years (range 17 to 63
years) who had initiated litigated claims via retained attorneys in
response to disputed injuries by employers. Individuals who score
between the 50th and 75th percentiles on the PCS are considered at
206 D.M. Davydov, S. Perlo / Physiology & Behavior 152 (2015) 203–216moderate risk for the development of chronicity. Individuals who score
above the 75th percentile would be considered at high risk for the de-
velopment of chronicity.
Whereas other broader measures of affect (depression and anxiety)
include both ﬂuctuations in positive and negative affect dimensions in
general, the PCS exclusivelymeasures the extent towhich pain exagger-
ates negative self-esteem or belief (i.e., pain's impact on subject's pessi-
mistic view) in cognitive, behavioral, affective, and social domains [60,
61]. Catastrophizing is a personal assessment of impaired coping ability
with pain as a stressor that threatens health, well-being, and quality of
life in contrast to pain coping self-efﬁcacy. This factor has been shown
to contribute to pain-related disability beyond the variance accounted
for by pain intensity itself [62]. Though some neurophysiological ﬁnd-
ings showed independence of pain catastrophizing from the actual
pain status, it is not always evident whether a patient's emotional dis-
tress (negative affectivity) and catastrophizing (negative cognition) ac-
tually overlap and reﬂect the same domain. Therefore the concept and
terms ‘catastrophizing’, ‘magniﬁcation’, ‘helplessness’, and ‘rumination’
with respect to “chronic pain and thebrain”disorders have been consid-
ered controversial [63,64]. The present studywas considered to also test
the possible independence between pain catastrophizing and pain
emotional distress with a multiple regression analysis. It allows for
partitioning the total variance into the variances (reﬂected in regression
coefﬁcients or partial slopes) uniquely explained by each predictor var-
iable (e.g., pain catastrophizing) independently of other, i.e., statistically
controlled, predictors (e.g., pain emotional distress).
2.5. Disability measures
The Pain Disability Questionnaire (PDQ) consists of 15 numerical
rating scales (ranging from 0 to 10) assessing the association of pain
with generalized functional (ability/disability) status (PDQ_f; range
from 0 to 90) and psychosocial behavior activity (PDQ_p; range from
0 to 60) with the total ranging from 0 to 150. It was speciﬁcally devel-
oped to measure the association of chronic functional impairment
with musculoskeletal disorders attributed to pain and demonstrates a
higher degree of responsiveness compared to other disability scales
[51,52]. At present, ratings of pain-related impairment and WPI
(whole person impairment) are based on PDQ [49]. A degree of pain
control was extracted from item 9 of PDQ andwas used as an additional
separate covariate in the models of pain and CV relationships.
The Oswestry Disability Index [ODI] (also known as the Oswestry
Low Back Pain Disability Questionnaire) is the oldest instrument that
researchers and disability evaluators use to measure a patient's perma-
nent functional status and disability associated with low back pain fo-
cusing primarily on the physical activities of daily living, with only
minimal attention given to psychosocial factors [51,65].
2.6. Covariates
Besides demographic variables (age, sex, and BMI) and a period from
injury to examination (duration of chronic pain or pain chronicity;
months), several scales estimating quality of life (mental, physical,
and functional health status; 36-Item Short Form Health Survey
[SF36]), mood and sleep problems (e.g., Patient Health Questionnaire
[PHQ-9] and Pittsburgh Sleep Quality Index [PSQI]), personality traits
or dispositions (e.g., Personality Psychopathology Five and Broad Per-
sonality Characteristics subscales of Minnesota Multiphasic Personality
Inventory-2 [MMPI-2]) and individual response styles (e.g., Validity
scales of MMPI-2) were serially included in statistical models to evalu-
ate their possible confounding, mediating, or moderating effects on
relationships between pain and CV measures. A full list of scales
and their subscales, which were used as covariates, is presented in Sup-
plementary data (Table 1S). Administration of multiple questionnaires
provided the assessment of consistency of responding. At the time of
the interview, some subjects were also examined with otherpsychosocial instruments with overlapping questions, which were not
considered in the present study (see supplementary Table 2S). Those
questionnaires were not selected for this pilot study, because they were
either less standardized, or presented only occasionally in the database
of this sample: i.e., they were included in the MLE later or were canceled
earlier (as redundant) by SP, than the time when cardiovascular protocol
was accepted by him for the MLE.
Current use of speciﬁc antihypertensive agents, psychotropic drugs,
and other painmedicines including opioidswas recorded, but not consid-
ered as covariates in the present study, because these drugs did not con-
stitute sufﬁcient groups for the control of their speciﬁc effects as ﬁxed
factors. Their possible effects were considered as a random factor in the
present study. Moreover, a large population and prospective study
showed no signiﬁcant moderating effect of these drugs on relationships
between similar measures of affective condition and orthostatic and
orienting CV responses [27]. All subjects included in the study had been
under pain control treatment. Degree of pain control by medication or a
non-drug method of treatment was examined as a possible covariate.
2.7. Cardiovascular measures
Systolic and diastolic blood pressures (SBP and DBP) and heart rate
(HR) were recorded in the left arm with a digital automated sphygmo-
manometer (HEM-7220-ZCS, OMRONCorp., Kyoto, Japan) during a spe-
cially designed 2 × 2 CV measurement protocol, which integrated
previously suggested procedures for the measurement of CV changes
in response to orthostatic and psychosocial challenges [27,40]. In the
present design the MLE protocol, including a complex of cognition,
emotion and behavior evaluation tests, having to recall traumatic inju-
ries followed by periods of being unable towork introduces a psychoso-
cial evaluation stress or challenge to the subject. This satisﬁes meeting
the respective formal criteria: i.e., the combination of (i) elements of un-
controllability and (ii) high levels of social-evaluative threat [66]. This
methodological conceptualisation was based on our previous ﬁndings
of the stressfulness of a similar interview in a general population [27].
It was conﬁrmed by a measure of cardiac metabolic activity (rate-pres-
sure product) that indicated higher values before and lower values after
the interview comparable to those in response to orthostatic stress.
Other studies have also indicated that higher values of rate-pressure
product can be similarly induced by physical and mental stressors [67,
68]. Moreover, both interview and orthostatic responses were also con-
cordant in predicting mean scores and changes of mood across 4-years
[27]. This allowed not having to introduce another social threat task to
assess CVR in response to psychosocial evaluation stress.
The CV measurement protocol was administered on the ﬁrst day
(Day 1) of the MLE. It consisted of two sessions. Session 1 was an initial
(‘orienting’) measurement session conducted in the morning shortly
after the subject's arrival. Session 2, the afternoon session,was conduct-
ed at the end of Day 1 upon completion of computer administered
psychodiagnostic testing, i.e. the MMPI-2 and completion of self-
report questionnaires (i.e., ‘after habituation or sensitization to exami-
nation’). CV changes between the two sessions were considered to rep-
resent an individual's capability for regulating (increasing or inhibiting)
arousal associated with orienting/habituation behavior in response to a
psychosocial challenge, whichmay be impaired in chronic pain [69–71].
The time between the two sessionswas estimated for a possiblemoder-
ation effect.
At both sessions, the subjectwas challengedwith the same orthostatic
procedure: postural change from a period of lying downwith eyes closed
for 6–8min to standing upwith eyes open for the next 6–8min. CV activ-
ity was measured 4 times during the lying posture and then 4 times after
standing up with intervals of at least 1 min between the readings at each
session based on clinical concern that cardiovascular activity stabilized.
Standing posture was taken a minute after the last CV reading during
lying. Impairments in baroreﬂex regulation of CV arousal during this or-
thostatic process was indexed by CV changes (i) between postures
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postures (i.e., between CV readings) of both sessions. CV changes be-
tween and within postures were considered to represent an individual's
capability for regulating (increasing and inhibiting) arousal associated
with level of alertness in response to posture changes, which may be im-
paired in chronic pain [35].
The subject remained still, and neither the subject nor the technician
talked during theCVmeasurements. No direct painmeasurementswere
performed in any positions. In both positions the cuff was at the same
level as the subject's heart. Sixteen single readings of SBP, DBP and HR
with date and timeof recordswere obtained for each subject. Additional
CV measures (mean arterial pressure [MAP=DBP+ (SBP− DBP) / 3],
pulse pressure [PP=SBP−DBP], rate-pressure product [RP=HR ∗ SBP])
were calculated and included in the analyses.
Different CV or hemodynamic variables (SBP, DBP, HR, MAP, PP, and
RP) were selected to evaluate relationships between pain measures and
the reactivity of CV system with respect to different psychophysiological
and physiological mechanisms. For example, SBP and DBP variations
were previously found to be independently related to positive or negative
affect regulation, to psychosocial (interviewing) or physical (orthostatic)
challenge, and to low or high intensity exercise, respectively [27,41,72].
Variation of HR reactivity was found to be signiﬁcantly related to bodily
sensation associated with an approach-avoidance motivational dimen-
sion and was also used as a psychosomatic ﬁtness measure [73–75].
Reactivity of other CVmeasures (MAP, PP, andRP)were evaluated to
detect the transfer of independent CV activities to integrative hemody-
namic processes. For example, RP detects reciprocal or unidirectional in-
tegrative change in mechanisms determining SBP and HR responses to
challenges and distinguishes conditions with more energy cost or
more energy economic cardiac metabolism. From a wide variety of
hemodynamic measurements, RP reactivity or RP reserve has been pre-
viously found to be the strongest predictor of cardiovascular mortality
and mood change [27,76–78]. The MAP can be conceptualized as the
sum of central venous pressure and the product of systemic vascular re-
sistance and cardiac output. The PP is proportional to stroke volume and
inversely proportional to the compliance of the aorta and peripheral re-
sistance. MAP and PP responses can exhibit, respectively, absolute and
relative reciprocal or unidirectional integrative change in mechanisms
determining cardiac and vascular responses to challenges.
2.8. Statistical analysis
Descriptive and inferential analyses were performed by SPSS (SPSS
Science, Chicago, IL) using Pearson product–moment correlation, Gen-
eral Linear Models by Type III method (GLM) and an additional SPSS
macro command set to evaluate signiﬁcance and conﬁdential intervals
of moderation (by Johnson–Neyman technique) and mediation (by
bootstrapping) effects of regression analyses [79]. Differences at
p b .05 were regarded as signiﬁcant. All parameter estimates are
expressed as non-standardized (B) regression coefﬁcients and their
standard errors (SE). Where necessary, a partial η2 was reported as a
measure of strength of association (effect size), which is comparable
to R2 expressing the percentage of explained variance. Sex as categori-
cal, and age and BMI as quantitative variables were included in all
models to adjust for these factors.
To provide evidence for conceptual validity of effects (i.e., to de-
crease the risk of making Type I and Type II errors; (74)), the main hy-
pothesis and related ﬁndings of relationships between CV and pain
variables were tested in a ﬁrst group of analyses using three different
statisticalmodels or analytic approaches (see Figure 1S in Supplementa-
ry data): proﬁle and trend analyses using the GLM procedure (trend
analyses are presented in Text 1S in Supplementary data), and media-
tion analysis using the bootstrap procedure.
The GLM procedure of the ﬁrst group of analyses was conducted
with repeated readings (measures) of CV (SBP, DBP, HR, MAP, PP, and
RP) treated as continuous dependent variables representing multiplemeasurements to test interaction effects between 3 within-subject fac-
tors (factor 1: 2 Sessions as 2 points of orthostatic challenge nested
within [before and at the end of] psychosocial challenge; factor 2: 2 Pos-
tures as 2 points of orthostatic lying-to-standing challenge; and factor 3:
4 Readings as 4 points of CV readings during each posture) and subjec-
tive pain-related ratings also treated as continuous independent vari-
ables. The GLM Repeated Measures procedure provided multivariate
analyses of interaction effects of these within-subject challenge factors
and subjective pain measures on CV changes (e.g., Session ∗ Pain sever-
ity, Posture ∗ Readings ∗ Pain distress, Posture ∗ Pain chronicity or Ses-
sion ∗ Posture ∗ Readings ∗ Pain catastrophizing) as proﬁle analyses.
These proﬁle analyses tested the ‘parallelism’ null hypothesis [80],
which asked whether CV changes between sessions, postures, or read-
ings showed the same pattern (i.e., similar proﬁle) with respect to indi-
vidual differences in the subjective variables. Themultivariate approach
to repeated measures does not require the compound symmetry and
sphericity assumptions. All multivariate F values were obtained by the
Pillai's Trace statistic, which is equivalent to partial η2 and R2 measures
of effect size, and tolerant of the violation of homogeneity of variance-
covariance matrices.
Simpler post-hoc regressionmodels within the ﬁrst group of analyses
were used to inspect those relationships, whichwere found signiﬁcant by
more complex (proﬁle) analyses to detect theCV changes (differences be-
tween separate pairs of CV readings)withmaximum impact in the effects.
In addition, signiﬁcant relationships were evaluated for cut-off points for
respective pain severity, pain distress, and pain catastrophizing scales,
and the period of pain chronicity/duration giving the best-ﬁtting models
(selected by Akaike Information Criterion) for presenting these relation-
ships in ﬁgures with possible clinical implications.
Mediation models of the ﬁrst group of analyses were applied to eval-
uate causality relationships between CV reactivity, pain measures, and
disability scales by using bias corrected and accelerated (BCa) bootstrap
procedure with 1000 bootstrap resamples to generate non-parametric
95% conﬁdence intervals (CI) of regression coefﬁcients from empirical
sampling distribution. The bootstrap procedurewas suggested as a robust
alternative to inference based on parametric assumptions (such as nor-
mally distributed errors) to conﬁrmﬁndings obtainedbyparametric anal-
yses and is recommended for reporting inferences in scientiﬁc reports
[75].
A second group of analyses inspected themodelswith signiﬁcant rela-
tionships between CV changes and pain measures for possible mediation
mechanisms of those relationshipswith respect to dispositional affect, be-
havioral, and cognitive coping or response styles. All mediation effects
were evaluated for conﬁdential intervals of regression coefﬁcients by
the bootstrap procedure included in the SPSS macro command set.
A third group of analyses inspected themodels with signiﬁcant rela-
tionships between CV changes and pain measures for possible con-
founding or moderation mechanisms with respect to the coping and
response styles (e.g., “abnormal illness behaviors”) by the same SPSS
macro command set. The Johnson–Neyman (J–N) technique included
in the SPSSmacro command setwas used to detect regions of signiﬁcant
relationships in the cases of signiﬁcant moderation effects. Since some
questionnaires were included in the medical-legal examination proto-
col later than others, degrees of freedomvaried in the different analyses.
Heterogeneity of subjects in some domains (e.g., demographics, asso-
ciated medical conditions, speciﬁc drug use) was considered as random
factors in the present study. The heterogeneity was expected to decrease
the effect size of the linear relationships of interest, but could not be fully
controlled in this retrospective study.
3. Results
3.1. Relationships between demographic, pain, and disability variables
Pain severity, distress, and catastrophizing, as well as PDQ_f, PDQ_p,
and ODI did not signiﬁcantly differ between men and women or
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catastrophizing scores were higher in White subjects compared to
Non-Whites (respective Bs[SE] = 4.67[1.97] and 28.46[14.07], ts[p] =
2.37[.023] and 2.02[.049], η2 = .12 and .08). Although all obtained rela-
tionships were found to be similar for the overall Pain Catastrophizing
Scale and its 3 subscales, of these three Catastrophizing subscales pain
magniﬁcation was found to be the most independent from other pain-
related (pain severity and pain distress)measures in the present sample
(Pearson's correlation coefﬁcients for pain distress scores with scores of
total catastrophizing scale and rumination, helplessness, andmagniﬁca-
tion subscales were 0.58, 0.58, 0.56, 0.45, respectively). Therefore pain
magniﬁcation effects were chosen to demonstrate relationships of the
pain catastrophizing measure to other variables in further analyses.
The pain activity limitation subscale of RDIP and ODI highly correlated
with PDQ_f (rs = .88 and .86, p b .001) showing similar relationships
with the pain measures (data not shown), and therefore were consid-
ered redundant measures of functional disability in this sample.
3.2. Relationships between pain severity, pain-related disability, and CV
changes
3.2.1. Proﬁle analysis
Signiﬁcant Session ∗ Pain Severity interactions were obtained for
SBP, DBP, MAP, and RP responses (Table 2). Fig. 1 (CV values averaged
across two postures) and 2aS present this pain-related effect on
between-session CV changeswith 9 as a cut-off point of chronic pain se-
verity. Post-hoc analyses found that individualswith lower pain severity
showed a decrease of CV arousal level from session 1 to session 2 com-
pared to those with higher pain severity. Moreover, parameter esti-
mates showed that individuals with lower pain severity also had
signiﬁcantly higher absolute SBP andMAP levels at session 1 compared
to those with higher pain severity (respective Bs[SE] = 13.86[5.84] and
8.53[4.17], t[p] = 2.74[.023] and 2.05[.047], η2 = .12 and .10). All these
pain severity effects on CV change between sessions were greater
during the lying position compared to standing (e.g., for SBP: respective
Pillai's Trace = 0.31, F(1, 40) = 18.02, p b .001 compared to Pillai's
Trace = 0.10, F (1, 40) = 4.62, p = .038).
3.2.2. Mediation analysis
Mediation analysis conﬁrmed the ﬁndings of the proﬁle analysis by
showing, e.g., that the pain severity measure signiﬁcantly mediated re-
lationships between SBP changes and both PDQ measures (Bs[SE] =
0.52[0.21] and 0.28[0.14], 95% CIs = 0.15–1.05 and 0.05–0.63 forTable 2
Session (2 points of psychosocial challenge) × Chronic Pain Severity (continuous and
dichotomized) interaction effects on a proﬁle (change) of cardiovascular (CV) activitya
obtained from systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial
pressure (MAP), pulse pressure (PP), heart rate (HR), and rate-pressure product (RP)
readings.
CV
measures
Chronic pain severity
Continuous Categorical,
low/high
Categorical,
low/highb
Pillai's
Tracec
F
(1, 40)
Pillai's
Tracec
F
(1, 40)
Pillai's
Tracec
F
(1, 35)
HR .02 0.76 .03 1.20 .02 0.53
DBP .12 5.29⁎ .26 14.07⁎⁎⁎ .26 12.35⁎⁎⁎
SBP .15 6.90⁎ .22 11.56⁎⁎ .17 6.95⁎
MAP .15 7.10⁎ .28 15.69⁎⁎⁎ .25 11.75⁎⁎
PP .07 2.86 .06 2.54 .02 0.75
RP .14 6.33⁎ .24 12.43⁎⁎⁎ .16 6.75⁎
a After adjustment to Sex, Age, and BMI variables.
b After an additional adjustment to two other pain measures (pain distress and
magniﬁcation) as continuous covariates.
c Pillai's Trace value is equivalent to partial η2 and R2 measures of effect size.
⁎ p b .05.
⁎⁎ p b .005.
⁎⁎⁎ p b .001.respective PDQ_f and PDQ_p). A lower SBP level at session 1 compared
with SBP level at session 2 corresponded with higher ratings of chronic
pain severity, which in turn were associated with higher ratings of
impaired functional and psychosocial abilities.
3.3. Relationships between pain distress, pain-related disability, and
CV changes
3.3.1. Proﬁle analysis
Signiﬁcant Posture ∗ Readings ∗ Pain Emotional Distress interactions
were obtained for SBP, PP, and RP responses (Table 3). Fig. 2 (CV values
averaged across two sessions) and 2bS present these pain-related effects
on between- andwithin-posture CV changeswith 6.3 as a cut-off point of
the pain distress measure. Post-hoc analyses showed that individuals
with lower pain distress signiﬁcantly differed from those with higher
pain distress by a SBP proﬁle during a transition from a late lying period
to early and mid periods of standing (Pillai's Trace = 0.32, F(3, 38) =
6.03, p = .002; marked by a circle in Fig. 2a). This effect was mirrored
by PP and RP proﬁles with an area restricted to the early and mid-
periods of standing posture (respective Pillai's Trace = 0.10, F(3, 40) =
4.31, p = .044; Pillai's Trace = 0.26, F (3, 39) =6 .74, p = .003; marked
by circles in Fig. 2b and c). Higher distress was associated with a relative
decrease of CV reactivity at mid-point after standing up compared to an
opposite proﬁle of CV change associated with a lower distress.
3.3.2. Mediation analysis
Mediation analysis conﬁrmed the ﬁndings of the proﬁle analysis by
showing, e.g., that the pain distressmeasure signiﬁcantlymediated rela-
tionships between the SBP changes during amid-period of standing and
both PDQ measures (Bs[SE] = 1.05[0.52] and 0.89[0.43], 95% CIs =
0.29–2.48 and 0.27–1.91 for respective PDQ_f and PDQ_p). A relatively
lower mid-response of SBP to orthostatic challenge corresponded with
higher ratings of chronic pain distress, which in turn were associated
with higher ratings of impaired functional and psychosocial abilities.
3.4. Relationships between pain magniﬁcation/catastrophizing,
pain-related disability, and CV changes
3.4.1. Proﬁle analysis
Signiﬁcant Posture ∗Readings ∗ PainMagniﬁcation interactionswere
obtained for SBP, MAP, PP, and RP responses (Table 4). Fig. 3 (CV values
averaged across two sessions) and 2cS present these pain-related effects
on between- and within-posture CV changes with 50 as a cut-off point
of the pain magniﬁcation measure. Post-hoc analyses showed that indi-
viduals with lower pain magniﬁcation signiﬁcantly differed from those
with higher pain magniﬁcation by a SBP proﬁle during a transition
from the late lying period to early and mid periods of standing (Pillai's
Trace = 0.34, F(3, 43) = 7.43, p b .001; marked by a circle in Fig. 3a).
This effect was to some extentmirrored byMAP, PP, and RP proﬁles (re-
spective Pillai's Trace=0.15, F(1, 45)=7.74, p= .008; Pillai's Traces=
0.18 and 0.23, Fs (2, 44)=4.74 and 6.43, ps= .014 and .004;marked by
respective circles in Fig. 3b–d). Higher magniﬁcation was associated
with a relative increase of CV reactivity at early point (i.e. immediately)
after standing up compared to an opposite proﬁle of CV change associ-
ated with a lower magniﬁcation.
3.4.2. Mediation analysis
Mediation analyses conﬁrmed the ﬁndings of the proﬁle analysis by
showing, e.g., that the pain magniﬁcationmeasure signiﬁcantlymediat-
ed relationships between the SBP changes during an early period of
standing and both PDQ measures (Bs[SE] = 0.43[0.35] and 0.28[0.21],
95% CIs = 0.04–1.47 and 0.03–0.91 for respective PDQ_f and PDQ_p).
A relatively higher early response of SBP to an orthostatic challenge
corresponded with higher ratings of chronic pain magniﬁcation, which
in turn were associated with higher ratings of impaired functional and
psychosocial abilities.
Fig. 1. Between-session cardiovascular (A — systolic blood pressure, SBP; B — diastolic blood pressure, DBP; C — mean arterial pressure, MAP; D — rate–pressure product, RP) changes,
which were found to be signiﬁcant between groups of individuals with high and low pain severity scores (cutoff point = 9) assessed by the RDIP scale. Presented data were averaged
for posture and reading factors within each session.
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and CV changes
3.5.1. Proﬁle analysis
Signiﬁcant Posture ∗ Pain Chronicity interactions were obtained for
HR and RP responses (Table 5). Fig. 4 (CV values averaged across two
sessions) and 2dS present these pain-related effects on between-Table 3
Posture (lying/standing challenge) × Readings (4 points) × Pain Emotional Distress
(continuous and dichotomized) interaction effects on a proﬁle (change) of cardiovascular
(CV) activitya obtained from systolic blood pressure (SBP), diastolic blood pressure (DBP),
mean arterial pressure (MAP), pulse pressure (PP), heart rate (HR), and rate-pressure
product (RP) readings.
CV
measures
Pain emotional distress
Continuous Categorical,
low/high
Categorical,
low/highb
Pillai's
Tracec
F
(1, 39)
Pillai's
Tracec
F
(3, 38)
Pillai's
Tracec
F
(3, 33)
HR .01 0.10 .02 0.24 .03 0.34
DBP .02 0.31 .04 0.53 .06 0.66
SBP .22 3.60⁎ .42 9.16⁎⁎ .41 7.73⁎⁎
MAP .06 0.76 .14 2.15 .17 2.20
PP .18 2.81⁎ .26 4.34⁎ .16 2.04
RP .11 1.55 .21 3.34⁎ .24 3.42⁎
a After adjustment to Sex, Age, and BMI variables.
b After an additional adjustment to two other pain measures (pain severity and
magniﬁcation) as continuous covariates.
c Pillai's Trace value is equivalent to partial η2 and R2 measures of effect size.
⁎ p b .05.
⁎⁎ p b .001.posture CV changes with 37 months as a cut-off point of the pain
chronicity measure. Individuals with a relatively shorter pain duration
(for about 3 years) had signiﬁcantly weaker HR and RP contrasts be-
tween the lying and standingpostures comparedwith thosewith longer
pain duration (more than 3 years) showing the stronger orthostatic HR
and RP contrasts.
3.5.2. Mediation analysis
While a direct effect of pain chronicity on PDQ measures was
positive (longer pain duration determined more impaired functional
and psychosocial abilities; Bs[SE] = 0.47[0.15] and 0.35[0.12], 95%
CIs = 0.17–0.77 and 0.11–0.59 for respective PDQ_f and PDQ_p), a lon-
ger pain duration through a relatively higher HR response to orthostatic
challenge corresponded with lower ratings of disability considering
the existence of an autonomic mechanism with protective effect
(Bs[SE] = −0.14[0.10] and −0.09[0.07], 95% CIs = −0.44 − −0.02
and −0.34 − −0.003 for respective PDQ_f and PDQ_p). Additional
two-mediator models indicated that the protective effect of this auto-
nomic mechanism on the behavioral abilities was transferred through a
general pain-killing effect (longer pain chronicity→higher HR response
to orthostasis→ lower pain severity, distress, or magniﬁcation→ lower
pain disability; data not shown), though direct effects of the chronicity
on these pain measures and further to disability were inductive (data
not shown).
3.6. Associations between CV changes and pain measures with respect to
coping styles
A series of mediation and moderation analyses were conducted to
further specify uniqueness of the indicated CV mechanisms associated
Fig. 2.Orthostatic cardiovascular (A— systolic blood pressure, SBP; B— pulse pressure, PP;
C — rate–pressure product, RP) changes, which were found to be signiﬁcant between
groups of individuals with high and low pain-related emotional distress scores (cutoff
point=6.3) assessed by the RDIP scale. Patterns showingmaximumsigniﬁcant difference
between the groups are included in circles. Presented data were averaged for two sessions.
Table 4
Posture (lying/standing challenge) ∗ Readings (4 points) ∗ PainMagniﬁcation (continuous
and dichotomized) interaction effects on a proﬁle (change) of cardiovascular (CV)
activitya obtained from systolic blood pressure (SBP), diastolic blood pressure (DBP),
mean arterial pressure (MAP), pulse pressure (PP), heart rate (HR), and rate-pressure
product (RP) readings.
CV
measures
Pain magniﬁcation
Continuous Categorical,
low/high
Categorical,
low/highb
Pillai's
Tracec
F
(1, 43)
Pillai's
Tracec
F
(3, 38)
Pillai's
Tracec
F
(3, 33)
HR .03 0.36 .06 0.92 .22 3.18⁎
DBP .05 0.74 .05 0.80 .14 1.89
SBP .32 6.67⁎⁎⁎ .37 8.51⁎⁎⁎ .33 5.73⁎⁎
MAP .17 2.82⁎ .18 3.09⁎ .27 4.29⁎
PP .22 4.12⁎ .20 3.50⁎ .16 2.23
RP .23 4.35⁎ .29 5.84⁎⁎ .21 3.16⁎
a After adjustment to sex, age, and BMI variables.
b After an additional adjustment to two other pain measures (pain severity and distress)
as continuous covariates.
c Pillai's Trace value is equivalent to partial η2 and R2 measures of effect size.
⁎ p b .05.
⁎⁎ p b .005.
⁎⁎⁎ p b .001.
2 In particular, the J-N technique showed that the confounding effects were associated
with lower scores of a positive mood CES-D subscale (cutoff = 3), higher scores of GAD-
7 anxiety (cutoff = 6), higher scores of subjective anxiety subscale of BAI (cutoff = 10),
high scores of MMPI-2 F-K (raw cutoff = 16), F (T cutoff = 82), TRIN (66), Fp (72), 1
(Hs) (83), 3 (Hy) (81), 6 (Pa) (68), RC3 (65), RC4 (53), OBS (66), HEA (76), CYN (65),
ASP (62), Mt. (72), Ho (67), PSYC (65), Pd4 (62), Sc1 (74), Sc3 (79), Pa1 (76), Pa2 (64),
Ma1 (57), HEA2 (88), CYN1 (63), CYN2 (61), ASP1 (61), LSE2 (59) scales, and low scores
of MMPI-2 K (41), S (41), Do (37), Pa3 (41) scales.
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to emotional and behavioral coping and response styles (data only re-
ported for SBP). No signiﬁcant mediation, confounding, or moderation
effects on the relationship between pain measures and SBP changes
were obtained for time difference between sessions, the extent of pain
control, the period from injury to examination (pain chronicity;
months), and the presence and longevity of cumulative trauma as-
sociated with the work injury accident.3.6.1. Pain severity
Sex-role behavior style evaluated by MMPI-2 5 (Mf) scale partially
mediated the association between pain severity and SBP change be-
tween sessions detected by the respective proﬁle analysis (B[SE] =
0.22[0.14], 95% CI= 0.01–0.61). Low pain severity scores corresponded
with lower scores on theMasculinity–Femininity scale (i.e., with bias to
amasculine gender role), which in turnwere associatedwith higher SBP
level at session 1 and its steeper decrease by session 2.
Maladaptive affect-regulation proﬁle (high scores of affective and
physical complaints), borderline and antisocial behaviors, maladaptive
thinking proﬁle (e.g., irrational and maladaptive beliefs), as well as a
“fake bad” response style (over-reporting or exaggeration of negative
symptoms) estimated by MMPI-2 decreased effect size of relationship
between pain severity and SBP change between sessions (data not
shown).2 Ethnicity was also found to be a signiﬁcant moderating factor
with African-American origin as a confounding factor of the relation-
ship, but only when SBP was measured during a standing position
(B[SE] = 1.39[0.67], 95% CI = 0.03–2.75).
3.6.2. Pain distress
The association between SBP change to standing up and pain-related
emotional distress detected by the respective proﬁle analysis was total-
ly mediated by (i) depression severity as indexed by CES-D and PHQ-9
scales (respective Bs[SE] = 0.07[0.04] and 0.09[0.05], 95% CI = 0.01–
0.18, 0.01–0.22), and (ii) clinical anxiety severity in general, and its ‘sub-
jective anxiety’ and ‘neurophysiologic arousal’ dimensions as indexed
by BAI (respective Bs[SE] = 0.11[0.05], 0.08[0.04], and 0.16[0.05], 95%
CIs = 0.03–0.22, 0.01–0.20, 0.06–0.27) included separately in the anal-
ysis. Lower SBP level at mid-point after standing up corresponded with
higher depression and anxiety, which in turn was associated with high
scores of pain-related emotional distress.
Low scores of affective and physical complaints, and high scores of
behavioral disinhibition, sensation seeking, masculine, and extraverted
Fig. 3.Orthostatic cardiovascular (A— systolic blood pressure, SBP; B—mean arterial pressure,MAP; C— pulse pressure, PP; D— rate-pressure product, RP) changes, whichwere found to
be signiﬁcant between groups of individuals with high and low painmagniﬁcation scores (cutoff point= 50) assessed by the PCS scale. Patterns showingmaximum signiﬁcant difference
between the groups are included in circles. Presented data were averaged for two sessions.
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good” response style (denial of problems) decreased effect size of rela-
tionships between orthostatic mid-point SBP level and pain-related
emotional distress (data not shown).33.6.3. Pain catastrophizing/magniﬁcation
Relationship between high SBP level at early point after standing up
and high pain magniﬁcation was totally mediated by disturbances in all
emotional, cognitive, and behavioral domains associated with the deﬁ-
cit in the core motivational and ego-mastery mechanisms of coping
with challenges indexed by high scores of negative mood subscale of
CES-D (B[SE] = 0.61[0.32], 95% CI = 0.09–1.36), cognitive dimension
subscale of BDI-II (B[SE] = 0.61[0.32], 95% CIs = 0.09–1.37), PTSD as
indexed by the PCL-C scale (B[SE] = 0.68[0.36], 95% CI = 0.04–1.46),
low scores of defensiveness, high scores of demoralization, dysfunctional
negative emotions, obsessiveness, severe depression, low self-esteem,
high work interference, high scores of negative treatment indicators,
manifest anxiety and depression, low ego-strength, low dominance,
high scores of college maladjustment, PTSD, low social imperturbability,
lack of ego mastery, high scores of self-doubt, lowmotivation as indexed
by theMMPI-2K, RCd, RC7, OBS, DEP, LSE, LSE1,WRK, TRT, TRT1, A, Es, Do,3 In particular, the J-N technique showed that the confounding effect was associated
with high scores of SF36-PF (cut-off = 29), SF36-BP (29), SF36-GH (33), SF36-VT (36),
SF36-SF (25), SF36-RE (26), SF36-MH (23), SF36-PCS (33), SF36-MCS (25) scales, lower
scores of negative mood CES-D subscale (cutoff = 9), clinical depression as indexed by
BDI-II scale (cutoff = 15), and ‘subjective anxiety’ subscale of BAI (cutoff = 7), low scores
of MMPI-2 FBS (T cutoff = 81), RBS (44), 1 (Hs) (83), 3 (Hy) (82), 7 (Pt) (76), D5 (64),
DEP2 (65), LSE1 (56), RC1 (76), HEA (78), HEA1 (72), Hy4 (79), and higher scores of 9
(Ma) (53), RC9 (45), GM (45), AGGR (54), DISC (49), Ma1 (46), Ma3 (54), ANG1 (53).
Confounding effect was also associated with lower scores of chronic pain severity as
indexed by RDIP scale (cut-off = 14).Mt., Pk, Pd3, Sc4, and Sc5 scales (Bs[SE] = 0.54–1.23[0.28–0.39], 95%
CIs = 0.09–2.16) included separately in the analysis. Higher SBP level at
an early point after standing up corresponded with a higher deﬁcit in
the core motivational and ego-mastery mechanisms, which in turn was
associated with high scores of pain-related magniﬁcation.
High scores of affective and physical complaints and high scores of
behavioral inhibition, and sensation avoidance behavior style decreased
the effect size of relationships between orthostatic early SBP level and
pain magniﬁcation (data not shown).4 Race was also found to be a
signiﬁcant moderating factor with Non-White origin of subjects as a
confounding factor of the relationship (B[SE] = 2.20[0.85], 95% CI =
0.49–3.91).4. Discussion
This study conﬁrmed the hypothesized relationship between cardio-
vascular reactivity and chronic pain in a heterogeneous population as
predicted by previous studies conducted inmore homogeneous groups.
Three different physiological mechanisms regulating blood pressure
changes in response to psychosocial evaluation and orthostatic chal-
lenges were found to be independently related to the subjective4 In particular, the J-N technique showed that the confounding effect was associated
withhigh scores of CES-DandBDI-II somatic complaints subscales (respective cutoffs=11
11and 10), higher scores of depression and anxiety as indexed by PHQ-9 andGAD-7 scales
(respective cut-offs = 14 and 11), higher scores of BAI ‘subjective anxiety’ and ‘neuro-
physiological arousal’ subscales (respective cut-offs = 11 and 8), poor sleep efﬁciency as
indexed by PSQI scale (cutoff = 2), higher level of daytime sleepiness as indexed by ESS
scale (cutoff = 12), high functional disability as indexed by ODI scale (cutoff= 44), lower
emotional role as indexed by SF36-RE scale (cutoff = 26), higher scores of MMPI-2 1(Hs)
(T cutoff = 84), 2(D) (78), 3(Hy) (84), 7(Pt) (75), RC1 (80), HEA (81), R (66), D1 (72), D2
(65), D4 (73), low scores of DISC (44) and RBS (43).
Table 5
Posture (lying/standing challenge) × Pain Chronicity (months; continuous and dichoto-
mized) interaction effects onaproﬁle (change) of cardiovascular (CV) activitya obtained from
systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP),
pulse pressure (PP), heart rate (HR), and rate-pressure product (RP) readings.
CV measures Pain chronicity
Continuous Categorical, low/high
Pillai's Traceb F (1, 45) Pillai's Traceb F (1, 45)
HR .19 10.35⁎⁎ .19 10.66⁎⁎
DBP .03 1.55 .08 3.66
SBP .00 0.06 .00 0.00
MAP .02 0.83 .03 1.40
PP .01 0.37 .04 1.94
RP .14 7.30⁎ .10 4.88⁎
a After adjustment to sex, age, and BMI variables.
b Pillai's Trace value is equivalent to partial η2 and R2 measures of effect size.
⁎ p b .05
⁎⁎ p b .005.
212 D.M. Davydov, S. Perlo / Physiology & Behavior 152 (2015) 203–216experience of pain in three different domains: (i) as a negative somatic
sensation that challenges physical well-being and related functional
abilities (physical activity; e.g. activities of daily living); (ii) as a negative
emotional feeling that challenges psychosocial well-being (symptomat-
ic distress and negative affective reactivity); and (iii) as negative think-
ing that challenges cognitive functioning (motivational well-being and
volitional activity). Cardiovascular indicators related to these mecha-
nismswere found to be tolerant of “fake-bad” response styles (exagger-
ation and over-reporting of negative symptoms, e.g., high scores on
MMPI-2 TRIN, F, Fp, FBS and F-K scales and low scores on MMPI-2 K
and S scales) and of “fake-good” response-styles (understatement of
negative symptoms and/or denial of problems, e.g., Non-White origin
of subjects and low scores on MMPI-2 FBS and RBS scales).
In contrast to the present study most previous studies of chronic
pain (i) have included populations of patients, whose painwas associat-
ed with very speciﬁc diagnoses or impairments (e.g., [1,2,35,37,44]),
that restricted generalization of ﬁndings; (ii) have investigated mainly
one dimension of pain (e.g., sensational [13,26]), which did not test
the speciﬁcity of detected markers with respect to other pain dimen-
sions or domains (e.g., emotional and cognitive); (iii) have conducted
group-wise analyses between patients and healthy controls [13],
which did not specify, whether the indicator is related to any speciﬁc
pain dimension (i.e., sensational, emotional and cognitive) or to a
general pain-related impairment when compared to healthy controls;
(iv) have obtained measures without control for psychosocial context
and habituation to it, where stressfulness could modulate pain experi-
ence and the impact of pain on physiological processes (e.g., [3]); andFig. 4. Orthostatic cardiovascular (A— heart rate, HR; B— rate–pressure product, RP) changes,
chronicity (cutoff point = 37 months) assessed by the period from injury to examination. Pres(v) have not demonstrated the tolerance of ﬁndings and indicators
with respect to patients' credibility and response styles (e.g., [37]).
4.1. Main ﬁndings
Findings in this report show that higher pain sensation severity is
associated with reduced cardiovascular arousal in response to a signiﬁ-
cant event, the beginning of a medical-legal examination as a social
evaluative threat. Previous studies suggest that transient increases in
blood pressure are associated with a central sympathetically mediated
hypoalgesic effect to an acute pain stimuli as a component of a stress re-
sponse [81]. This mechanism does not seem impaired in those subjects
showing a nonextinguished arousal response (high cardiovascular
(re)activity at session 1) in the presence of a chronic pain syndrome.
It correspondswith a recent ﬁnding that patients with a longer duration
of chronic neck pain demonstrate a lower cardiovascular responsive-
ness to an acute psychosocial stressor [44]. This allows for considering
the association between higher pain severity and the absence of orienting
behavior [27]. As a consequence, upon completion of the examination day
(re-testing in session 2) the absence of cardiovascular habituation
(e.g., absence of systolic blood pressure decrease)was found in those sub-
jects. It was especially observed in systolic and mean arterial pressures
measured during a quiet non-demanding condition (lying with closed
eyes). The same impairment was found in diastolic blood pressure and
rate-pressure product changes. This dysregulation was also found to be
an objective predictor of pain-related functional disability indicated by
Pain Disability Questionnaire and tolerant to maladaptive response styles
and to effects fromother pain-relateddimensions (emotional distress and
cognitive distortion or catastrophizing). Orthostatic proﬁles (patterns)
were similar in both sessions (see Tables 3 and 4, and Fig. 2S). This allows
considering that the effect of pain severity on cardiovascular change be-
tween sessions (i.e., in response to long psychosocial evaluation) does
not signiﬁcantly affect predicted relationships between other paindimen-
sions (emotional distress and cognitive distortion or catastrophizing) and
cardiovascular responses to orthostatic challenge.
Altered regulation of cardiovascular response to the orthostatic chal-
lenge (stress) were found to be related to individual styles of behavioral
coping (emotional and cognitive) with chronic pain-related stress. The
relative increase of cardiovascular reactivity instead of a decrease at
an early point of orthostatic challenge (i.e., 0–2 min after standing up)
was associated with greater pain magniﬁcation (a component of pain-
related catastrophic thinking), and was an additional objective predic-
tor of the degree of functional disability. It was observed in systolic
blood pressure and rate-pressure product, andmirrored in mean arteri-
al and pulse pressure changes. This impairment of cardiovascular
response may be attributed to the dysregulation of early cardiac andwhich were found to be signiﬁcant between groups of individuals with high and low pain
ented data were averaged for two sessions and for 4 readings within each posture.
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In addition, the appearance of a relative decrease of cardiovascular
response instead of its increase atmid-point during the orthostatic chal-
lenge (i.e., 2–3min after standing)was associatedwith higher emotion-
al distress andwas another objective predictor of functional disability. It
was also observed in systolic blood pressure and rate-pressure product,
andmirrored in pulse pressure change. This impairment in cardiovascu-
lar response may be attributed to the dysregulation of later cardiac and
vascular baroreﬂex functioning after standing up from lying [33,82,83].
The painmagniﬁcation and the emotional distress effects on orthostatic
cardiovascular responses were found to be independent of each other.
Additionally analysis showed that the control of their co-occurrence or
confounding misrepresentation in self-ratings could double the effect
size of their counterparts.
Upright posture requires a rapid and effective skeletal muscle pump,
neurocardiac, neurovascular, and neurohumoral compensations to
maintain blood pressure, cerebral blood ﬂow, and consciousness. The
integrative response is the combination of several compensatory re-
sponses. For example, within-subject changes in pulse pressure predicts
within-subject changes in cardiac output in response to physical exer-
cise [84]. Thus pain distress effect on a coupled drop of systolic and
pulse pressures and on drop in cardiac metabolic activity with no effect
on diastolic pressure in response to orthostatic stress can be associated
with the impairment of cardiac component of baroreﬂex in blood pres-
sure regulation. Indeed the gravitational stimulus increases the involve-
ment of baroreﬂex pathway in the control of blood pressure in healthy
subjects, but its reduced strength (i.e., reduced efﬁciency of the cardiac
baroreﬂex control) was found during the active standing in patients
with a chronic pain syndrome coupled with a high negative affectivity
[34,85–87]. This may determine instability of systolic and pulse pres-
sure levels in such subjects during orthostasis indicated in the present
study. However, the pain magniﬁcation effect on a coupled rise of sys-
tolic and mean arterial pressures and on a lesser drop in pulse pressure
(in response to orthostatic stress) can be associated with a centrally en-
hanced sympathetic driving of the heart and vessels permanently
retained by this negative cognition that affects baroreﬂex regulation of
blood pressure when actively standing [35].
Central sensory and affective pain processes may share common
sensory mechanisms. However, pain magniﬁcation in particular and
pain catastrophizing in generalmay not be related to central nociceptive
processing although playing an important role in the development of
chronic pain [63,88,89]. Indeed, a previous study found an interaction
effect of higher catastrophizing about pain and lower cardiovascular
(e.g., systolic and diastolic blood pressures) reactivity to an anger or
sadness recall interviewwith the greatest pain [37]. In previous studies,
pain-related emotional distress was also found to be directly and indi-
rectly connected with both pain catastrophizing and pain severity [1,60,
90–92]. One of mechanisms for these effects may be associated with the
common central role of dopaminergic systemsmodulating pain sensation
and its affective and cognitive processing [93].
Duration or chronicity of painful condition was found to affect pain-
related disability in two different ways: negatively (longer pain dura-
tion → stronger orthostatic HR response as indicator of pain-killing,
-coping, or -protective mechanism→ lower severity of pain symptoms
in general→ lower pain-related disability) and positively (longer pain
duration → higher severity of pain symptoms in general → higher
pain-related disability). The same stronger orthostatic HR response as-
sociated with a larger vaguswithdrawal capacity due to higher baseline
vagus activity was described as an indicator of a general resilience or
protectivemechanism against trauma in a recent study [75]. Level of ac-
tivity of this mechanism can be inherited (e.g., byMTHFRmutation) or
acquired (e.g., by regular physical activity).
Taken together the main ﬁndings from this report suggest that im-
pairment of cardiovascular auto-regulation associated with the severity
of behavior disabilitymay be estimated during speciﬁc ‘behavior transi-
tion’ periods claiming changes in energy metabolism. It is consistentwith the concept of evolutionary correspondence between the strength
of cardiovascular reactivity to challenges and metabolic demands for
copingwith challenges [27]. Altered cardiovascular response to a stress-
ful (medical) examination was considered to be associated with the
physical component of pain affecting orienting behavior in response to
arousing event. Fluctuations of cardiovascular response to orthostasis
were associated with the effect of emotional and cognitive motivational
components of pain on arousal or alertness regulation when standing
from lying. Chronic ﬂuctuations in response to orthostatic stress
(i.e., fast interchanges between profound increases and excessive de-
creases of blood pressure level) may cause a cerebral ischemic reperfu-
sion injury leading to cell death and tissue damage in vulnerable people
[94–96]. Resulting brain damage may trigger further neuropsychiatric
syndromes. These are detected as mediation factors in the present
study. They may then trigger maladaptive affect-regulation (affective
and physical complaints), maladaptive thinking (irrational beliefs) or
both response styles. This depends on human vulnerabilities (see
below). Conﬁrming this hypothesis requires further in depth investiga-
tion of neurophysiological and neurohumoral mechanisms associated
with these changes in blood pressure regulation with the application
of more sophisticated neuroimaging and neuroimmune methods and
techniques [47,97,98]. Cardiac chronotropic response to orthostatic
stress is considered to be an indicator of a general protective vagus
mechanism counteracting pain impairment effects on physical, emo-
tional and cognitive functioning during illness chronicity.
4.2. Findings of mediation and moderation analyses
Additional mediation analyses suggested possible mechanisms that
contribute to the relationships between cardiovascular reactivity regu-
lation and individual pain severity levels, pain-related emotional dis-
tress and magniﬁcation/catastrophizing. For example, higher scores on
the Masculinity–Femininity scale of the MMPI-2 (i.e., scoring higher in
a feminine direction of human traditional sex-typed behavior) partly
mediated the relationship between impaired cardiovascular reactivity
and severity of chronic pain. Some researchers consider that the extent
of male or female role playing in societies is under the inﬂuence of sex
steroid hormones presenting during prenatal development [99–101].
Our ﬁnding and this consideration are in accord with other ﬁndings
that estrogens and anti-androgens could facilitate chronic pain develop-
ment and inhibit mechanisms for coping with it [102–104]. It is also
concordantwith other studies showing that elevations on theMasculin-
ity–Femininity scale of the MMPI-2 predicted (i) a higher number of
chronic pain conditions at 30-year follow-up and (ii) the presence of
chronic pain symptoms [105,106]. However, in contrast to chronic pain,
elevations on this scale predicted a longer acute pain non-experience
after surgery (i.e., longer duration of anesthesia post-effect) [107]. Anoth-
er part of the relationship between the impaired orienting cardiovascular
response and chronic pain severitywas left unexplained by themediation
analysis. This suggests additional uncovered physiological mechanisms
(e.g., associated with race or ethnic differences in sensitivity to pain and
its chronicity), which could also be involved in chronic pain development
or coping with it [21,108].
Moderation analyses found that the relationship between self-
reports of pain severity and cardiovascular change between sessions
could be confounded or biased in part of the present clinical sample
by individual response styles associatedwith: (i) “faking bad” (exagger-
ation of negative symptoms); (ii) borderline and antisocial personality
traits; (iii) maladaptive affect-regulation proﬁles including deep con-
cerns about physical symptoms, somatization and conversion reactions;
and (iv)maladaptive thinking proﬁles. The latter includes poor impulse
control, high irritability, low tolerance for frustration, low self-conﬁdence,
lack of ego mastery, social alienation, and disorganized, bizarre, or
disoriented thinking, and irrational beliefs. Moreover, the observed effect
of pain severity on between-session cardiovascular changeswas indepen-
dent of both defensive response styles and affective states.
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appeared to be managed by an approach motivation mechanism for
coping with pain using the ‘maladaptive affect-regulation proﬁle.’ This
includes intentional and unintentional help-seeking strategies. Previ-
ously this personal proﬁle was found in patients managing chronic
pain with medication-overuse, but without other substance addiction
problems [109,110]. Self-reports related to this ‘affective’ pain dimen-
sion could be confounded or biased by a “fake-good” response style.
Such subject may present with denial of impaired behaviors and nega-
tive events and a “macho” masculine sex role (e.g., stoic denial of
aches, pains, complaints, or weaknesses; denial of psychological fears
or problems), antisocial behavior, risk-taking behavior, impulsivity,
sensation seeking traits, behavioral disinhibition, amorality, extrover-
sion, and high suspiciousness of others with feelings of hostility and
resentment.
In contrast to pain-related distress, ourﬁndings suggest that the pro-
cess of painmagniﬁcation/catastrophizing seemed to bemanaged by an
avoidancemotivationmechanism for copingwith pain that is associated
with general withdrawal strategies. This is found in persons with mal-
adaptive thinking spectrums (demoralization, low self-esteem, low
ego-strength and -mastery, low dominance and motivation, high self-
doubt, maladjustment, and work interference, obsessiveness, negative
treatment indicators) and with the presence of posttraumatic stress
disorder symptoms. Previously, this personality proﬁle was found in pa-
tients with substance addiction problems [109]. Moderation analyses
also detected that self-reports associated with this spectrum could be
confounded by affective symptoms and physical complaints, as well as
Non-White origin of subject who had lower scores of both pain severity
and pain catastrophizing.
Thus, MMPI-2 results in chronic pain subjects in our study demon-
strate a three-cluster solution for pain-related response styles when cop-
ing with the effects of chronic pain. It may be described as a masculine-
feminine (sex role), with maladaptive affect-regulation (social approach
motivation, excessive ‘energy’, and non-cognitive or somatic-emotional
symptoms), and maladaptive thinking (social avoidance motivation, low
‘energy’, and cognitive-emotional symptoms).
4.3. Limitations and perspectives
Although the medical-legal examination in this study was consid-
ered as a psychosocial stressor it was not previously used as a situation
with social evaluative threat. Nevertheless, the present results support a
previous ﬁnding that ﬂattened cardiovascular reactivity to a social
evaluative threat can indicate a chronic pain experience [44]. The
study was conducted in a relatively small sample. The present ﬁndings
have also not distinguished whether cardiovascular arousal was caused
by experiencing or by coping with pain. Other questionnaires which
were used in the examination, but which were not included in the
study might have additional confounding effects thereby diminishing
the observed effect sizes of relationships between cardiovascular and
subjective measures. It thus requires caution in the interpretation of re-
sults. We therefore propose the conﬁrmation of these ﬁndings in other
studies. Some methodological inconsistency in chronic pain measure-
ment can obscure the interpretation of association of pain severity and
cardiovascular measures between studies. Severity of chronic pain can
be evaluated as a current pain magnitude or intensity, e.g., by a visual
analog scale, or as a long-lasting trait by assessment of frequency of
pain experience and pain duration [111]. Association of cardiovascular
reactivity with chronic pain severity assessed as a current or acute
condition may be closer to the acute pain effect [112], but may be
more related to the pain duration or burdening effects if assessed as a
chronic trait [44,57].
In a mixed clinical group of chronic pain subjects results from this
study nonetheless suggest for the ﬁrst time that properties of a scientiﬁ-
cally validated cardiovascular metric can be used to assess chronic pain
in threemain dimensions/domains (as a physical sensation, as emotionaldistress, and as catastrophic thinking) as it relates to whole person im-
pairment and to disability. It is this understanding whichmay potentially
beneﬁt clinicians seeking to assess symptomatic distress from chronic
pain (irrespective of its origin) and chronic pain-related functional im-
pairment or disability in patientswith limited education or ability to com-
municate. The identiﬁed autonomic markers of pain impairment effects
along with an autonomic marker of the protection effect against pain
may also help painmedicine practitionerswhen selecting andmonitoring
interventions for speciﬁc pain control. For example, in some instances, pa-
tients may beneﬁt from interventions that improve emotional well being
or cognitive control of painwith little actual impact on pain intensity. One
of the most vital beneﬁts, that identiﬁcation of these indicators offer, is to
impact decision-making regimens when individualizing treatment.
Therefore, results from this study suggests that clinical recognition of
pain severity associated with frequency and magnitude of pain episodes
versus pain related emotional distress versus pain magniﬁcation/
catastrophizing introduces the option of targeting a treatment interven-
tion or combination of interventions that are most relevant for managing
human suffering in the chronic pain patient on an individual basis.
5. Conclusion
In sum, we suggest that preliminary results from this study identify
a translational physiologic assessment protocol that enables a more ac-
curate three-dimensional understanding of suffering in chronic pain
subjects. If this assessment protocol is conﬁrmed it will help clinicians
to bypass uncontrollable and debilitating biopsychosocial stressful life
events confounding clinical pain assessment.
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